Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression

Abstract

BackgroundReprogrammed energy metabolism as an emerging hallmark of cancer has recently drawn special attention since it facilitate cell growth and proliferation. Recently, long noncoding RNAs (lncRNAs) have been served as key regulators implicated in tumor development and progression by promoting proliferation, invasion and metastasis. However, the associations of lncRNAs with cellular energy metabolism in lung cancer (LC) need to be clarified.MethodsHere, we conducted bioinformatics analysis and found insulin-like growth factor binding protein 4–1 (IGFBP4–1) as a new candidate lncRNA located in the upstream region of IGFBP4 gene. The expression levels of lnc-IGFBP4–1, mRNA levels of IGFBP4 in 159 paired lung cancer samples and adjacent, histological normal tissues by qRT-PCR. Over-expression and RNA interference (RNAi) approaches were adopted to investigate the biological functions of lnc-IGFBP4–1. The intracellular ATP level was measured using the Cell Titer-Glo Luminescent Cell Viability Assay kit, and changes in metabolic enzymes were examined in cancer cells and normal pulmonary epithelial cells with qRT-PCR.ResultsOur results showed that lnc-IGFBP4–1 was significantly up-regulated in LC tissues compared with corresponding non-tumor tissues (P < 0.01), and its expression level was significantly correlated with TNM stage (P < 0.01) and lymph node metastasis (P < 0.05). Further investigation showed that overexpression of lnc-IGFBP4–1 significantly promoted LC cell proliferation in vitro and in vivo, while downregulation of endogenous lnc-IGFBP4–1 could inhibited cell proliferation and induce apoptosis. Moreover, we found lnc-IGFBP4–1 could influences ATP production levels and expression of enzymes including HK2, PDK1 and LDHA, in addition, decline in both ATP production and these enzymes in response to 2-DG and 2-DG-combined Rho123, respectively, was observed in lnc-IGFBP4–1-overespressing LC cells, indicative of an enhanced aerobic glycolysis rate. Finally, lnc-IGFBP4–1 was observed to negatively correlate with gene IGFBP4, and lower expression level of IGFPB4 was found after lnc-IGFBP4–1-overexpression was transfected into PC9 cells, higher expression level of IGFPB4 was also found after lnc-IGFBP4–1-downregulation was transfected into GLC-82 cells, which indicates that IGFBP4 may exert its targeting function regulated by lnc-IGFBP4–1.ConclusionsTaken together, these findings provide the first evidence that lnc-IGFBP4–1 is significantly up-regulated in LC tissues and plays a positive role in cell proliferation and metastasis through possible mechanism of reprogramming tumor cell energy metabolism, which suggests that lnc-IGFBP4–1 may be a promising biomarker in LC development and progression and as a potential therapeutic target for LC intervention.Electronic supplementary materialThe online version of this article (10.1186/s12943-017-0722-8) contains supplementary material, which is available to authorized users.

Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway

“…For example, lncRNA AKHE promotes tumor progression in hepatocellular carcinoma (HCC) via activation of NOTCH2 signaling [27]. Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer (LC) cell proliferation and metastasis and inhibits apoptosis [28]. Similarly, lncRNA LINC01296 overexpression upregulates the expression of MYCN and promotes cell viability, migration, and invasion in human cholangiocarcinoma (CCA) cells [29].…”

Regulatory roles of long noncoding RNAs implicated in cancer hallmarks

“…Other mechanisms by which lncRNAs modulate glycolysis have also been documented. For instance, the lncRNA IGFBP4‐1 influences ATP production and expression of specific enzymes, including hexokinase 2 (HK2), pyruvate dehydrogenase kinase 1 (PDK1) and lactate dehydrogenase A (LDHA), and the aerobic glycolysis rate in lung cancer …”

Unique metastasis‐associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma

“…Increasing evidence shows that lncRNAs play a critical role in cancer biology. Dysregulation of lncRNAs often serves as an independent predictor for poor prognosis of cancer patients . Our group has previously reported that circulating lncRNAs act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer .…”

“…Dysregulation of lncRNAs often serves as an independent predictor for poor prognosis of cancer patients. [5][6][7][8][9] Our group has previously reported that circulating lncRNAs act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer. 10 Several recent studies have focused on the involvement of lncRNAs in tumor metastasis because these lncRNAs have shown great promise in the discovery of new biomarkers for predicting prognosis in individual patients.…”